Your #1 Source for Cannabis, Ethnobotany & Psychedelic News, Culture, Health & How-To's
Australian MDMA, psychedelic mushroom studies to move to recruitment phase
Posted on January 13 2021
This year, four Australian institutions will start recruiting for separate research into using psilocybin and MDMA for PTSD, addiction, depression and anxiety.Edith Cowan and Monash universities will begin separate trials...
Psilocybin & migraine: First of its kind trial reports promising results
Posted on December 01 2020
A first-of-its-kind exploratory study, led by researchers from Yale School of Medicine, has found a single dose of the psychedelic psilocybin found in so called 'Magic Mushrooms' can reduce migraine...
Psilocybin-assisted psychotherapy for the treatment of Major Depressive Disorder: Preliminary results from a randomized controlled trial
Posted on July 19 2019
Less than two years ago, the amazing scientists at the Johns Hopkins Psychedelic Research Unit began studying the effects of Psilocybin, one of the main psychoactive substances found in magic...
Reclassification Recommendations for Drug Found in 'Magic Mushrooms'
Posted on October 02 2018
If phase III clinical trials are successful, researchers recommend reclassification of the drug psilocybin (which is found in magic mushrooms) from Class A to schedule IV in the USA, which...